Showing results (211-220 of 276) with videos related to
Sort By:
Pageof 28
NMR in Biomedicine|May 8, 2000
Distinction between normal and renal cell carcinoma kidney cortical biopsy samples using pattern recognition of (1)H magic angle spinning (MAS) NMR spectraA R Tate, P J Foxall, E Holmes, et al.Physical Review Letters|June 1, 2004
Dissociation of a product of a surface reaction in the gas phase: XeF2 reaction with SiR C Hefty, J R Holt, M R Tate, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
The thioredoxin-1 inhibitor 1-methylpropyl 2-imidazolyl disulfide (PX-12) decreases vascular permeability in tumor xenografts monitored by dynamic contrast enhanced magnetic resonance imagingBénédicte F Jordan, Matthew Runquist, Natarajan Raghunand, et al.Journal of Substance Abuse Treatment|March 13, 2012
Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trialMatthew J Worley, Ryan S Trim, Scott C Roesch, et al.Journal of Forensic Sciences|March 1, 1995
Fatal anorectal injuries: a series of four casesC J Orr, M A Clark, D A Hawley, et al.Journal of Forensic Sciences|July 1, 1991
Fatal and near-fatal animal bite injuriesM A Clark, G E Sandusky, D A Hawley, et al.Journal of Forensic Sciences|March 1, 1993
Asphyxial deaths due to hanging in childrenM A Clark, J D Feczko, D A Hawley, et al.Journal of Acquired Immune Deficiency Syndromes|January 1, 1988
Seroprevalence and demographic information of patients at risk for human immunodeficiency virus (HIV) infection in Manitoba, CanadaG W Hammond, D Buchanan, R Malazdrewicz, et al.Clinical Chemistry|August 14, 1998
International Federation of Clinical Chemistry standardization project for the measurement of lipoprotein(a). Phase I. Evaluation of the analytical performance of lipoprotein(a) assay systems and commercial calibratorsJ R Tate, N Rifai, K Berg, et al.European Journal of Cancer (Oxford, England : 1990)|April 23, 2003
Increased incidence of renal parenchymal carcinoma in the Northern and Yorkshire region of England, 1978-1997R Tate, R Iddenden, P Harnden, et al.Pageof 28